We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
Cap. Flow
-$279M
Cap. Flow %
-15.76%
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$32.2M
2
A icon
Agilent Technologies
A
+$10.1M
3
INCY icon
Incyte
INCY
+$9.9M
4
APC
Anadarko Petroleum
APC
+$9.65M
5
NOW icon
ServiceNow
NOW
+$9.61M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$22.6M
2
AGN
Allergan plc
AGN
+$19.6M
3
CPRI icon
Capri Holdings
CPRI
+$18.6M
4
DAL icon
Delta Air Lines
DAL
+$17.6M
5
NTNX icon
Nutanix
NTNX
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 24.23%
3 Consumer Discretionary 14.95%
4 Industrials 7.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELF icon
301
e.l.f. Beauty
ELF
$4.95B
$582K 0.03%
54,948
-11,662
-18% -$104K
KNL
302
DELISTED
Knoll, Inc.
KNL
$576K 0.03%
30,475
+3,775
+14% +$74.9K
CGBD icon
303
Carlyle Secured Lending
CGBD
$710M
$574K 0.03%
39,647
+21,187
+115% +$312K
VSTO
304
DELISTED
Vista Outdoor Inc.
VSTO
$564K 0.03%
+70,472
New +$689K
CLS icon
305
Celestica
CLS
$36.6B
$557K 0.03%
+65,900
New +$588K
UTL icon
306
Unitil
UTL
$999M
$556K 0.03%
10,271
-1,448
-12% -$75.6K
PDS
307
Precision Drilling
PDS
$1.04B
$555K 0.03%
+11,699
New +$529K
APLS
308
DELISTED
Apellis Pharmaceuticals
APLS
$554K 0.03%
+28,400
New +$447K
PRFT
309
DELISTED
Perficient Inc
PRFT
$551K 0.03%
+20,122
New +$530K
FORR icon
310
Forrester Research
FORR
$185M
$542K 0.03%
11,200
– –
MODN
311
DELISTED
MODEL N, INC.
MODN
$539K 0.03%
30,710
-8,657
-22% -$138K
RDWR icon
312
Radware
RDWR
$1.23B
$536K 0.03%
20,500
-5,619
-22% -$137K
MOBL
313
DELISTED
MobileIron, Inc.
MOBL
$534K 0.03%
97,710
+17,719
+22% +$87.4K
NPKI
314
NPK International
NPKI
$1.19B
$533K 0.03%
58,225
-15,267
-21% -$131K
CYTK icon
315
Cytokinetics
CYTK
$10.9B
$513K 0.03%
63,431
+27,978
+79% +$206K
TNC icon
316
Tennant Co
TNC
$1.48B
$497K 0.03%
8,006
-2,121
-21% -$127K
ADTN icon
317
Adtran
ADTN
$769M
$490K 0.03%
35,800
– –
ARAY icon
318
Accuray
ARAY
$26.8M
$485K 0.03%
101,700
+4,200
+4% +$19.1K
HIVE
319
DELISTED
Aerohive Networks
HIVE
$479K 0.03%
105,782
+8,713
+9% +$36K
ZYNE
320
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$476K 0.03%
87,800
+34,400
+64% +$167K
HUD
321
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$474K 0.03%
+34,500
New +$487K
DOOR
322
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$441K 0.02%
8,839
-18,912
-68% -$1.01M
PRDO icon
323
Perdoceo Education
PRDO
$1.99B
$436K 0.02%
26,410
-9,690
-27% -$140K
HMHC
324
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$433K 0.02%
59,607
-18,522
-24% -$166K
FARO
325
DELISTED
Faro Technologies
FARO
$430K 0.02%
9,802
-1,816
-16% -$80.1K
11 12
13
14 15

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q1 2019 Portfolio in Review

As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.

  • PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
  • PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
  • PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
  • PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
  • PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
  • PDT Partners opened 90 new positions and closed 118 in Q1 2019.
  • PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.